Polypore (NYSE: PPO) received a number of price target changes and ratings updates during the last week:
- Polypore had its price target raised by analysts at UBS AG to $46.00. They wrote, “We reiterate our OUTPERFORM rating and are raising our price target to $46 (from $39) rolling forward valuation onto 2014 estimates. Our price target reflects a 16x 2014E EPS multiple (vs. on 2013E EPS previously), with the midteens multiple reflecting the growthy characteristics of Polypore’s lithium business and reduced downside risk versus expectations. Based on the closing price, shares of PPO are trading at 17.5x and 14.8x our 2013 and 2014 EPS estimates.”
- Polypore had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $46.00 price target on the stock, up previously from $39.00. They wrote, “We see moderate risk for Polypore’s 4Q12 EPS, where revenue was likely consistent with forecasts on healthy market demand, and confirmation of a sunset for one-time capacity expansion costs would be a positive. We forecast 4Q12 rev/adjusted EPS of $193.0m/$0.54 vs. the consensus $191.8m/$0.52. The company previously guided to 4Q12 adjusted EPS range of low-50 to low 60 cents. While it is possible Polypore could see one-time costs related to their capacity expansion that might weigh down EPS, we expect management to confirm this should be the last quarter where these expenses impact results as capacity additions should be materially complete.”
- Polypore was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” rating. They now have a $38.00 price target on the stock, down previously from $46.00.
- Polypore was upgraded by analysts at TheStreet from a “hold” rating to a “buy” rating. They wrote, “Polypore International (PPO) has been upgraded by TheStreet Ratings from hold to buy. Among the primary strengths of the company is its expanding profit margins over time. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.”
- Polypore was downgraded by analysts at Zacks from a “neutral” rating to an “underperform” rating. They now have a $34.60 price target on the stock.
Polypore opened at 36.72 on Wednesday. Polypore has a 52-week low of $30.39 and a 52-week high of $48.42. The stock’s 50-day moving average is currently $40.31. The company has a market cap of $1.710 billion and a price-to-earnings ratio of 24.28.
Polypore International, Inc. is a global high technology filtration company that develops, manufactures and markets specialized microporous membranes used in separation and filtration processes.